Immunovant IMVT
$31.77 −$0.75 (-2.31%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $31.51 -0.82%
Open$32.26
Prev close$32.52
Day range$31.61 – $32.77
Volume704.9K
Market cap$6.57B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts8
Average target$48.43+52.4% vs. price
- Buy 75%
- Hold 25%
Low $37.00Now $31.77Avg $48.43High $66.00
Recent rating changes
The last 20 actions on file set price targets from $37.00 to $66.00, averaging $48.58.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 12 Nov 2026 | J.P. Morgan | BUY | $49.00 |
| 10 Nov 2026 | Wells Fargo | BUY | $47.00 |
| 10 Nov 2026 | H.C. Wainwright | BUY | $41.00 |
| 9 Nov 2026 | Wells Fargo | BUY | $47.00 |
| 9 Nov 2026 | BofA Securities | BUY | $46.00 |
| 16 Oct 2026 | Wells Fargo | BUY | $45.00 |
| 12 Oct 2026 | BofA Securities | BUY | $45.00 |
| 26 Sep 2026 | LifeSci Capital | BUY | $53.00 |
| 25 Sep 2026 | Bernstein | HOLD | $37.00 |
| 24 Sep 2026 | Truist Financial | HOLD | – |
| 23 Sep 2026 | LifeSci Capital | BUY | $53.00 |
| 23 Sep 2026 | H.C. Wainwright | BUY | $41.00 |
| 21 Sep 2026 | Piper Sandler | BUY | $66.00 |
| 11 Aug 2026 | Stifel | BUY | $57.00 |
| 10 Aug 2026 | H.C. Wainwright | BUY | $41.00 |
| 10 Aug 2026 | J.P. Morgan | BUY | $50.00 |
| 7 Aug 2026 | LifeSci Capital | BUY | $53.00 |
| 7 Aug 2026 | Piper Sandler | BUY | $66.00 |
| 7 Aug 2026 | BofA Securities | BUY | $45.00 |
| 7 Aug 2026 | H.C. Wainwright | BUY | $41.00 |
No comments yet — be the first to weigh in on IMVT.
Sign in to join the discussion.